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Ca
2+ is an important second messenger participating in many cellular activities; when physicochemical insults deregulate its
delicate homeostasis, it acts as an intrinsic stressor, producing/increasing cell damage. Damage elicits both repair and death
responses; intriguingly, in those responses Ca
2+ also participates as second messenger. This delineates a dual role for Ca
2+ in
cell stress, making diﬃcult to separate the diﬀerent and multiple mechanisms required for Ca
2+-mediated control of cell survival
and apoptosis. Here we attempt to disentangle the two scenarios, examining on the one side, the events implicated in deregulated
Ca
2+ toxicity and the mechanisms through which this elicits reparative or death pathways; on the other, reviewing the role of Ca
2+
as a messenger in the transduction of these same signaling events.
1.Introduction:Ca2+ Signaling versus
Deregulation in Life and Death
Ca2+ is an ion involved in living processes in an atypical
way: if other cations participate to enzyme activity with-
out performing essential regulatory functions due to their
abundance in all cell compartments, Ca2+ has a peculiar
distribution, being present at very low levels in the cytosol
of eukaryotic cells; this enables it to act as a messenger
regulating cytosolic Ca2+-dependent enzymes and functions,
when and where its local concentration raises above the
steady-state level. For many decades the research on ion (and
speciﬁcallyCa2+)rolesincellphysiopathologywashampered
byintrinsictechnicaldiﬃculties.Abigimpulsecamewiththe
development of Ca2+-sensitive ﬂuorescent probes [1, 2], that
localizeinspeciﬁccellcompartments(cytosol,ER,andmito-
chondria) allowing separately and speciﬁcally evaluating
and quantifying Ca2+ compartmentalization; and with the
diﬀusion of instrumentations performing kinetic analyses,
which allowed performing accurate and quantitative analysis
of Ca2+ dynamics.
An eﬃcient Ca2+ signaling implies maintenance of Ca2+
homeostasis, which requires mechanisms keeping cytosolic
Ca2+ concentration ([Ca2+]c) low and stable. These include
active pumping against gradient by Ca2+ ATPases, enzymes
present on the cytosolic side of plasma membrane and
endoplasmic reticulum (ER) performing the high energy-
expensive task of pumping Ca2+ out of the cytosol against
gradient, or by ion exchangers (e.g., the Na+/Ca2+)[ 3].
Instead, signaling is exerted by discrete and highly con-
trolled ER membrane channels, originating local Ca2+ rises
possessing speciﬁc signaling roles, such as those regu-
lated by the phospholipase C-inositol-3-phosphate pathway
[3], or by cyclic (ADP-ribose) [4]. These local increases
activate/deactivate Ca2+-sensitive enzymes, eliciting signal
transduction chains aimed at controlling many diverse cell
functions such as mitosis, or activation, or motility or
apoptosis. As a feedback mechanism, the channels rapidly
c l o s ed u et ol o c a lh i g h[ C a 2+], which is rapidly extinguished
by cytosolic buﬀering proteins, by the Ca2+-ATPases and by
mitochondria, thus being in fact Ca2+ transients. To restore
ER homeostasis, the partially emptied ER is replenished by
Ca2+ entry from the extracellular space through controlled
opening of plasma membrane channels (capacitative Ca2+
entry, see below [5]), or by Ca2+ released from mito-
chondria present in the vicinity of inositol-3-phosphate2 International Journal of Cell Biology
(IP3) channels [6]. In the category of excitable cells, mainly
neuronsandmyocytes,plasmamembranechannelsopenfol-
lowing speciﬁc hormonal or physico-chemical stimulations,
even in the absence of previous ER emptying, and possess
signaling meaning of their own [7].
Ca2+ signaling requires the strict cooperation among
the diﬀerent cellular compartments and organelles, being
in fact a highly sophisticated way of communication
to maintain homeostasis and functionality of the whole
cell. In particular, much attention is being given to the
cooperation between ER and mitochondria, which interact
through highly dynamic physical connections [8] contain-
ing abundant Ca2+-mediating transport systems [9]. These
mediate the controlled reciprocal exchange of Ca2+ [10]
aimed at modulating and supporting each other functions
in the guise of an interorganellar symbiotic relationship
[11–13].
TheimportantimplicationofthelowcytosolicCa2+ con-
centration ([Ca2+]c) for cell homeostasis is that it must be
maintained low against gradient (extracellular space and the
internal Ca2+ stores such as ER, have 10,000 times as much
Ca2+),since excessor deregulated[Ca2+]cpose cellsin sucha
dramatic asset to be in fact cell-toxic. To this purpose, a wide
range of mechanisms are displayed, including high capacity
binding proteins, pumps and exchangers, and mitochondria,
which possess a low aﬃnity Ca2+ uniporter that sequesters
cytosolic Ca2+ when it reaches the dangerous threshold of
500nM, thus being a major detoxifying mechanism against
Ca2+ overload [14].
Failure of the mechanisms devoted to maintain Ca2+
homeostasis produces generalized Ca2+ alterations, in turn
producing rough cell damage, without involving speciﬁc
signaling meaning; when strong, Ca2+ alterations cause cell
death by necrosis [15–19].
What becomes clear after many years of intense studies
about the role of Ca2+ in cell stress response and death, is
that pathological Ca2+ alterations resulting from failure of
homeostatic controls coexist with regulated Ca2+ signaling.
The former produces rough damage that leads to cell repair,
orapoptosis, or necrotic cell death, according tothe intensity
of the damage, whereas the latter constitutes a controlled cell
response participating in survival or apoptotic pathway. This
recommends careful analyses to separate active responses
from passive changes.
2.Ca2+ andCellDamage
2.1. Ca2+ as an Intrinsic Stressor. Ca2+ deregulation is a
consequence of many diﬀerent insults that end up altering
Ca2+homeostasis, causing and increasing damage to cells;
for this reason, it may be deﬁned as an “intrinsic stress,”
meaning that it is autoinduced by the cells as a consequence
of an extrinsic stress of a diﬀerent nature. The proteins
controlling Ca2+ homeostasis are so many and so diverse
that it is quite likely that any insult or physico-chemical
alterations end up deregulating some of them, producing
a set of reactions that may not properly be deﬁned as
signaling (since it has no physiological purposes), but it
is nonetheless obliged by the presence of Ca2+-sensitive
determinants. What is lacking in such instances is the
coordination between the multiple pathways, which are
instead casually activated, overlapping and superimposing
one another, leading to cell collapse. The intrinsic Ca2+
stress may consist in either depletion of ER Ca2+,o r
increase of cytosolic (or mitochondrial, or nuclear) Ca2+,o r
both.
2.2. Damage by Ca2+ Overload. When stress leads to Ca2+
overload, Ca2+-produced damage may reach levels suﬃcient
to cause necrotic cell death [15–19]. Damage and death
are due to excess stimulation of Ca2+-sensitive targets,
which are numerous and concern key cellular functions:
many enzymes that control supramolecular assembly, or
degrading nucleic acids, lipids or proteins are Ca2+-sensitive.
Among them are m-calpains, activated by high Ca2+ levels
and implicated in cell death and in many neurologi-
cal disturbances [20]; lipoxygenases, and a set of Ca2+-
activated enzymes modifying arachidonic acid (AA) that
are major actors of the inﬂammatory response, and also
involved in apoptotic pathways [21]; phospholipases A2,
which liberate AA from phospholipids, thus favoring, in the
presence of high [Ca2+]mt mitochondria stress or collapse
[22]; a set of DNAses, one of which historical interest
for being the enzyme responsible for apoptotic laddering
[23].
A major form of damage is caused by the intervention
of mitochondria that, taking up the excess of cytosolic Ca2+
for scavenging purposes, may be subjected to stress and
even collapse if it exceeds a physiological threshold, therefore
increasing cell damage (see below) [14].
Another form of damage comes from energy failure,
which starves Ca2+-ATPases that stop pumping Ca2+ against
gradient from cytosol to ER, or to the extra-cellular
environment, thus simultaneously producing cytosolic Ca2+
overload and ER Ca2+ depletion.
Cytosolic Ca2+ overload is implicated in many serious
human pathologies.
Excitotoxicity is a major cause of neuronal cell death;
it develops as a consequence of problems occurring during
neurotransmission, in instances of excess of excitatory
signals, such as those from the neurotransmitter glutamate
[24], or of deregulated signaling; this ends up impairing the
tight control of Ca2+ channels, leading to Ca2+ overload [25]
and eventually cell death and neurodegeneration.
Ischemic and anoxic stress produce deep changes in cell
metabolism that, upon reoxygenation/reperfusion converge
into a dramatic, toxic increase of cytosolic Ca2+ [26, 27].
Such changes include plasma membrane depolarization,
which favors the opening of the plasma membrane Ca2+
channels thus promoting Ca2+ inﬂux [28]; and acidiﬁca-
tion, which causes the inversion of the Na+/Ca2+ plasma
membrane exchanger, which begins pumping Ca2+ within
cells [29]. Mitochondria may buﬀer Ca2+ and rescue cells in
instances of mild reperfusion stress; however, they paradox-
ically are the major cause of cell death in strong reperfusion
stress [30], since the huge Ca2+ overload stimulate Ca2+
overcharging and collapse through phenomena of Ca2+
cycling (see below [31]).International Journal of Cell Biology 3
Due to the increasing evidence that most (if not all)
pathologies involve, as etiological or concurrent agents,
alterations of oxidative metabolism leading to oxidative
stress, much attention was paid in the 80s and 90s to
the mechanisms through which oxidative stress causes
Ca2+ derangements. Although no deﬁnite picture is still
delineated, some key points have been clariﬁed. Oxidation
and redox imbalance cause ER and plasma membrane Ca2+
channels malfunctions, since their oligomeric active form is
controlled by disulﬁde bridges [32]; this increases [Ca2+]c
and depletes [Ca2+]er. Moreover, oxidative stress impairs the
buﬀering capacity of mitochondria, lowering the internal
Ca2+ threshold level of PTP opening [9, 33], thus depriving
the cells of one of the major Ca2+ detoxifying mechanisms.
All of these derangements are especially critical for
neurons, where Ca2+ is crucial to neuronal functions [34],
implying that they possess more controlling steps that can
be altered. Moreover, cell death is most devastating for
tissues rich in post-mitotic cells, such as cardiomyocytes
or neurons, which are diﬃcult to replace; indeed, most
neurodegenerative conditions are characterized by neuronal
death caused by Ca2+ overload [34]. The scenario is even
more dramatic considering that the organs that mostly
depend on post-mitotic, Ca2+-sensitive cells are heart and
brain,whosefailurecausesimmediatedeathoftheorganism.
2.3. Ca2+ Overload in Mitochondria. Mitochondria are very
important for intracellular Ca2+ homeostasis and signaling,
acting in fact as pivot of intracellular Ca2+ communications.
Any Ca2+ overload exceeding the cytosolic threshold of
500nMinvolvemitochondrialparticipation[14].Mitochon-
dria possess low aﬃnity (500nM) Ca2+ uniporters that
allow the accumulation of large amount of Ca2+ within the
mitochondrialmatrix,whichconstitutesahighcapacityCa2+
reservoir, allowing buﬀering [Ca2+]c increases over 500nM
[9, 14]. This mitochondria ability plays an important role
in cell homeostasis and cell signaling, because it help extin-
guishing cytosolic Ca2+ signals [35]. The resulting [Ca2+]mt
increase modulates mitochondrial activity (i.e., increases
ATP production [9, 11, 12]); moreover, overcharged mito-
chondriahelpsreﬁllingERafterphysiologicalCa2+ emptying
(e.g., after IP3-mediated signalling [13]). In instances of
mild [Ca2+]c increases originating from stressing events,
potentially toxic Ca2+ is sequestered within mitochondria,
and then released after the stress is over: in this instance
mitochondriaplayaprosurvivalrole.However,iftheamount
of sequestered Ca2+ exceeds mitochondrial capacity, it leads
to collapse through opening of the permeability transition
pores (PTP, formerly referred to as megachannel) [18, 19].
Since PTP is a multi-ion channel, the consequence is that
the captured Ca2+ ions are dissipated, creating new cytosolic
Ca2+ increase, which can be in turn taken up by new
intact mitochondria [18]. This creates cycles of Ca2+ uptake
and dissipation, recruiting more mitochondria, up to a
sort of mitochondrial suicide cascade. This phenomenon
was named Ca2+ cycling [18], and raised much interest
in the 80s; the interest then declined because it did not
support a clear physiological role, being rather considered
a futile cycle, because it does not help cells to survive.
Nowadays, a re-evaluation of this mechanism suggests that
Ca2+ cycling provides a physiological advantage [10]: PTP
opening by itself causes release of cytochrome c (even in
the absence of an upstream canonical apoptotic signaling
such as Bax translocation [19, 36, 37]), which in turn
may activate caspases and promote apoptosis [18], thus
transforming a necrotic cell death into a more physio-
compatible apoptosis. It seems worth mentioning here
that localized phenomena of mitochondria Ca2+ cycling
may have a pro-apoptotic signaling meaning since local
and controlled small episodes of cytochrome c release act
as initiators of the intrinsic pathway of apoptosis [38]
(see below).
Mitochondria can adjust their cellular localization by
movingaroundthemicrotubularnetwork[39];itistempting
to hypothesize that they reach positions required to per-
form Ca2+ detoxiﬁcation, or to modulate speciﬁc signaling
events, that is, extinguish some and exacerbating others,
according to need. As an example, acute oxidative stress
induces the reorganization of mitochondrial pattern from
pan-cytoplasmatic, to peri-nuclear (Ghibelli, unpublished
observation), possibly buﬀering excess ER Ca2+ leakage due
to oxidations. This scenario suggeststhatlocal Ca2+ increases
o fas t r e s sn a t u r e ,e v e no fas m a l le x t e n t ,m a yt r i g g e ra n
apoptotic signaling via recruitment of mitochondria.
2.4. Damage by Ca2+ Depletion (ER Stress). When referring
to intracellular Ca2+ depletion, the emphasis goes to emp-
tying of ER, which elicits what was recently recognized as
ER stress [40]. ER stress is caused by diﬀerent disturbances
aﬀectingERhomeostasis,suchasproteinmalfolding,glucose
starvation, disturbance of membrane turnover/synthesis, or
of protein traﬃcking, which all lead to ER vesiculation and
loss of function [40]. Ca2+ plays a key role in maintaining
ER structure, since the ﬂat shape of the cisternae is actively
kept by bridges constituted by high capacity Ca2+ binding
proteinssuchascalreticulin,calsequestrin,andcalnexin[41];
upon ER Ca2+ emptying, Ca2+ binding is lost, the bridges
weaken and ER resumes the low energy spherical shape of
lipids droplets in acqueoussolution, thus losing function. ER
stress, as any other stress, can evolve into repair or apoptosis.
In the ﬁrst instance, the stress response implies up-
regulation of stress proteins such as GRP78, a major luminal
ER protein [42] that plays a central role as ER stress sensor
displayingmultiplefunctions.Itcoordinatestheactivationof
other proteins implicated in ER stress, such as ATF6 [43], a
transcription factor transactivating prosurvival genes whose
promoters containing ER stress response elements (ERSEs)
[44]. GRP78 also promotes removal by autophagy of the
altered portions of ER by controlling the correct formation
of autophagosome [45]. Multifaceted is its ability to prevent
apoptosis [42, 46] :af r a c t i o no fG R P 7 8i sp r e s e n ta sa
transmembrane ER protein, exposing a cytoplasmic domain
able to directly interact and form an inhibitory complex with
caspase-7 and/or caspase-12 [42, 47]; GRP78 limits the pro-
apoptotic activation of c-Jun N-terminal kinase (JNK) [35],
normallyactingasatransducerofERstress[48];inaddition,
cell-free studies suggest a direct ability of GRP78 to control
mitochondria, by inhibiting cytochrome c release [47].4 International Journal of Cell Biology
If damage is severe, it triggers apoptosis. The mechanism
for ER stress-induced apoptosis is still not completely
clariﬁed. Big emphasis was given to caspase-12, which is
activated in ER membranes in instances of disruption of
ER Ca2+ homeostasis or accumulation of unfolded proteins
in the ER lumen of mice cell models. Caspase-12 initiates
apoptosis either in a mitochondrial-independent fashion
[49] or recruiting and activating mediators of the intrinsic
pathway of apoptosis [50]. This led to consider caspase-12 as
the general transducer of ER damage. However, caspase 12 is
present only in rodents, and to-date no functional caspase-
12 was identiﬁed in human cells (which in fact possess only
a pseudo-gene), nor a functionally equivalent protein. While
the search for a human equivalent of caspase 12 is still active
(especially concerning a possible role for caspase-4 [51]),
other caspase-independent scenarios, have been explored to
describe the transduction of the ER stress to apoptosis via
mitochondria. Recently, Klee et al. [52] provided evidence
that Ca2+ mobilization from the ER is required to initiate
the mitochondrial death pathway, by cooperating with the
eﬀectors of ER stress surveillance machinery IREa/TRAF2;
according to this model, Ca2+ promotes the JNK pro-
apoptotic pathway through a complex set of steps involving
the Bcl-2 family.
3.Ca2+ andC ellDeath
3.1. Historical Perspective. When the regulated, physiological
mode of cell death, apoptosis, came into the general interest,
the involvement of de-regulated Ca2+ rises as causative agent
of apoptosis was sought for, in the view that apoptosis
was a sort of “petit necrosis;” in particular, a Ca2+/Mg2+-
dependent DNAse was hypothesized, considering that DNA
laddering was the earliest apoptotic marker of a biochemical
nature to be widely accepted. The issue however never
came to a deﬁnite picture, because if an increase of [Ca2+]c
was indeed occurring in some examples of apoptosis, such
as the paradigmatic model of rat thymocytes treated with
corticosteroids [53], in many other instances it was a drop
in overall Ca2+ level the event that promotes apoptosis [54].
The paradox of this dual, opposite role of Ca2+ in apop-
tosisoccupiedseveralyearsofresearch.Thapsigargin(THG),
a (still) popular inducer of apoptosis, is an irreversible
poison of ER Ca2+-ATPases (SERCA), thereby inducing a
transient increase in cytosolic Ca2+ and a sustained depletion
of the ER Ca2+ pool [55]; since the two events occur
simultaneously, it is quite diﬃcult to assess the speciﬁc
contribution of one or the other to apoptosis. If the early
studies were taking for granted that the apoptogenic event
was the increase of [Ca2+]c, it was later shown that in many
instances intracellular Ca2+ buﬀering did not abrogate, but
even increased, THG-induced apoptosis, demonstrating that
also ER Ca2+ depletion was an apoptogenic event [56, 57].
In fact, in most instances [Ca2+]c rises in apoptosis
are not rough event, but precise signaling steps, such as,
for example, the Ca2+-dependent proteases calpains [58]o r
calmodulin [59]. The notion of apoptotic Ca2+ signaling
evolved, with not small eﬀort, together with the awareness
that apoptosis is not a “petit necrosis” but a regular signal
transductionchain,occurringinfunctioningcells,endingup
with coordinate cell demise instead of activation, or mitosis,
or transcription.
To-date, the issue of the actual role of Ca2+ in cell death
is still debated; the diﬀerent contributions of the diﬀerent
cells (e.g., excitable versus non-excitable; dividing versus
post-mitotic; tumor versus normal) and of the diﬀerent
apoptogenic treatments (stress or physiologic; allowing or
not protein neosynthesis, etc.) produce a whole continuum
of variations, and render it hard to interpret the thousands of
studies on the topic. However, some generalizations can be
attempted: ER Ca2+ depletion may elicit apoptosis through
the ER stress pathway [57, 60]; rough, stress-induced Ca2+
overloads produce necrosis [17, 19, 61]; regulated Ca2+
increases play a role as signaling events in the intrinsic
apoptotic pathway [62–65].
The poor knowledge of the role of Ca2+ in apoptosis,
which is perhaps surprising considering that Ca2+ dynamics
were among the ﬁrst alterations proposed as causative of
apoptosis, is also due to other, more intrinsic problems.
Among them the fact that Ca2+ transients are very much
localized in terms of space (i.e., cytosolic micro-domains)
and time (seconds), and it is very easy to miss them even
with sophisticated technologies. Also the asynchrony of
the apoptotic process hampers the analyses: even homoge-
neous cultured cells initiate apoptosis at diﬀerent moments
after stimulation, overlapping diﬀerent phases and render-
ing inappropriate any biochemical analysis performed in
bulk. These problems were overcome with technological
approaches allowing analysis at the single cell level [1, 2],
that is, living cell imaging and ﬂow cytometry, which are
beginning to shed light on the process, helping to separate
diﬀerent phases and diﬀerent subregions of Ca2+ signaling
[1, 2, 64, 65].
3.2. Stress-Induced Apoptosis: A General View. It is now
well established that the intracellular apoptotic signaling
evolves through at least two diﬀerent pathways, triggered
by ligand stimulation of death receptor (extrinsic pathway),
or by cell damage (intrinsic pathway) [66]. The extrinsic
pathwayisatypicalsignaltransductionconsistingofprotein-
protein interaction and conformational changes from the
very beginning, being induced by a molecular event such
as ligand-receptor interaction and culminating with caspase
activation and cell dismantling. The intrinsic pathway is
instead induced not by molecular, but by physicochemical
events, implying that (a) sensor(s) of micro-environmental
alterations or cell damage must be activated to promote
the apoptotic signal [67]; afterwards, a molecular signal
transduction chain of events similar to the extrinsic pathway
isactivated,alsoculminatingwithcaspaseactivation.Sensors
are proteins that are modiﬁed by physico-chemical alter-
ations such as pH, redox equilibrium, or Ca2+ levels, thus
acquiring the ability to trigger a molecular signal cascade.
The most upstream molecular event of the intrinsic pathway
is the translocation of Bax, which moves to mitochondria
and induces mitochondrial outer membrane permeabiliza-
tion (MOMP). The diﬃculty of ﬁnding molecular events
upstream of Bax activation suggested that Bax itself mightInternational Journal of Cell Biology 5
be a sensor of physico-chemical alterations. Indeed, recent
reports indicate that Bax activation can occur via direct
oxidation of cysteines [68, 69], or via proteolytical activation
by calpains [70].
3.3. Ca2+ Control of Cytochrome c Release. It is emerging a
pre- or early-commitment phase of the intrinsic apoptotic
pathway, occurring before MOMP, during which poten-
tial apoptotic signals, mostly relying on Ca2+ messages,
are selected and ampliﬁed by cross-talk between ER and
mitochondria [61]( Figure 1). MOMP is a set of diﬀerent
phenomena allowing release (or leakage, see below) of
a p o p t o g e n i cf a c t o r ss u c ha sc y t o c h r o m ec, SMAC/diablo,
AIF, through mitochondrial membrane pores. Cytochrome
c received most attention for its ability to nucleate the
apoptosome and to initiate the caspase cascade; its release
occurs through at least two diﬀerent mechanisms, the
apoptosis-speciﬁc Bax-based pore, and the PTP channel,
both of which can be modulated by Ca2+ in a very diﬀerent
way.
The relation between Ca2+ and cytochrome c release via
Bax consists of a feed-forward ampliﬁcation loop between
ER and mitochondria: local high concentrations of Ca2+
(such as those created by the Ca2+ eﬄux from IP3 channels)
favorthereleaseofcytochromec frommitochondriathrough
Bax pores [62, 71] on the one side; on the other, cytosolic
cytochrome c increases Ca2+ levels in the vicinity of IP3
channelsonER[38]byﬁxingthemintheopenconﬁguration
after a signaling stimulus, thus transforming a transient
ﬂux into a sustained one [38]. As a result of this interplay,
smallcytosoliccytochromec leakagemaypromotesecondary
and massive releases (i.e., that required for apoptosome
nucleation), via local Ca2+ messages [38]. This provides a
rationale to previous reports indicating that small amounts
of cytochrome c are released from mitochondria as a
very early step of apoptosis, with the goal of expanding
the signal [72]. Intriguingly, the Ca2+ sensitivity of Bax
mitochondrial pores seems to be limited to the intrinsic
pathway: when Bax is activated by the extrinsic pathway
via t-Bid [73] (i.e., death receptor stimulation in type 2
cell), the Bax pores are insensitive to Ca2+ modulation [62].
This indicates that active Bax is diﬀerent according to the
route of activation (i.e., damage versus t-Bid), suggesting
that multiple, alternative mechanisms for Bax activation may
exist, possibly leading to diﬀerent eﬀects on the folding and
functions of the protein [68, 70, 73].
PTP opening is an automatic response to excess
[Ca2+]mt, which causes the interaction between the inner
mitochondrial membrane complex adenine nucleotide
translocator (ANT) and the outer mitochondrial membrane
complexvoltage-dependentanionchannels(VDAC),leading
to the formation of the membrane-spanning PTP pore.
Cyclophilin D (Cyp-D) is a component of PTP resident
in the mitochondrial matrix, which is activated by high
[Ca2+]mt, favoring PTP opening by lowering the Ca2+
threshold required for ANT-VDAC interaction [74–76]. In
instances of mitochondrial Ca2+ overload, inhibitors of Cyp-
Dactivation,suchascyclosporins,contrastPTPopeningand
the eventual cell death, therefore exerting a net cell protective
eﬀect, which is often used in therapies to limit immune
deﬁciencies or neurodegenerations [76, 77].
ThemechanismofcytochromecreleaseviaPTPopening,
which was historically the ﬁrst mechanism proposed, is
still unclear from the molecular and functional point of
view (Figure 1). In fact, there is a topological problem.
In apoptosis cytochrome c is liberated from its natural
position on the outer side of the internal mitochondrial
membrane to the intermembrane space; thus, it requires
pores in the outer membrane to be released, whereas pores
that span the two membranes, such as PTP, would lead
to the release of molecules residing in the mitochondrial
matrix. To explain cytochrome c release via PTP, it may
be hypothesized that PTP may cause mitochondrial mem-
brane perturbations that allow cytochrome c (and other
factors) to leak rather than be speciﬁcally released. In such
instances,thegrossalterationscausedbyPTP-mediatedionic
redistribution will be necrogenic [78], even if cytosolic re-
localization of cytochrome c may circumstantially activate
caspases. Conceivably, the extent of PTP may determine
the ﬁnal outcome, and apoptosis or necrosis may follow
according to the strength of PTP. Indeed, Cyp-D inhibitors
are often reported to prevent cell death by necrosis. As an
alternative mechanism of cytochrome c relase via PTP, it was
suggested that a VDAC-only channel may form on the outer
membrane, with the help, but without the physical partic-
ipation, of ANT, thus connecting the cytosol not with the
matrix, as in the canonical PTP, but with the intermembrane
space, thus allowing cytochrome c release. This model is
supported by experiments performed in liver mitochondria
from mice knock out for ANT isoforms [79], where the
release of cytochrome c following an apoptogenic stimulus
still occurred, but the susceptibility to Ca2+ alterations in the
mitochondrial matrix was reduced. In this instance ANT, a
sensor of Ca2+ through its interaction with Cyp-D, plays the
regulatory function to transduce Ca2+ alterations to VDAC,
promoting its oligomerization and the formation of pores
mediating release of cytochrome c.
Bax pores and PTP are diﬀerent in molecular, mech-
anistic and functional term. However, they cooperate in
some examples of apoptosis to achieve cytochrome c release.
This implies physical interaction between Bax and PTP
components [80], such as Cyp-D or ANT [81]. The two
mechanisms of cytochrome c release also coparticipates
in the same induction pathway in a diﬀerent temporal
relationship, that is, a mild stress-induced PTP opening
ﬁrst causes a small cytochrome c leakage, which stimulates
via Ca2+ modulation (see above) a second intense Bax-
mediated release suﬃcient for caspase activation. The co-
operationbetweenthetwopores(andthetwopathways)also
providesamechanisticexplanationtotheestablishedbutstill
unexplained ﬁnding that Bcl-2, though not modulating PTP
directly [74], all the same provides protection to cells against
necrosis [82].
3.4. Control of Ca2+ by the Bcl-2 Family. The pro-apoptotic
protein Bax exerts its functions by inserting into membranes
and forming pores. Very well described is the anchoring
to mitochondrial membrane, where Bax forms, perhaps6 International Journal of Cell Biology
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Figure 1: Ca2+ signals between ER and mitochondria coordinate the precommitment phase of apoptosis: ampliﬁcation loops between Bax
activation and Ca2+ release from ER amplify cytochrome c release to a level suﬃcient for apoptosome nucleation and caspase activation.
Cytochrome c released by Bax (1) or VDAC (2) mitochondrial pores magniﬁes Ca2+ eﬄux from IP3 channels; the consequent local high
cytosolic Ca2+ recruits Bax (via calpain?) to mitochondria or ER membrane, stimulating more cytochrome c release and more Ca2+ eﬄux,
respectively.
with adjuvant proteins, pores of a size large enough to
allow passage of diﬀusible pro-apoptotic proteins such as
cytochrome c or SMAC [83–85]; the anti-apoptotic role
of the cognate Bcl-2, which integrates into mitochondrial
membranes also in healthy cells, is believed to be the
prevention of Bax pore forming, perhaps due to the extra
protein domain (BH4) shared by all anti-apoptotic members
of the family. It is now emerging that Bax and Bcl-2 play a
similar role also in the ER membranes, where they would
prevent or favor, respectively, Ca2+ leakage to the cytosol.
Bcl-2 is found within ER membranes of healthy cells,
where it prevents Ca2+ leaking from ER [63, 86]; as the
mechanism involved, it was proposed that Bcl-2 may work
as a pump additional to the SERCAs [56], and/or to prevent
IP3 channels opening [87].
In apoptosis, Bax translocates not only to mitochondria,
but also to ER membranes [63, 88], where it favors Ca2+
release from the ER lumen [62, 63], possibly after oligomer-
ization [71]; similar evidence was shown for the cognate
pro-apoptotic Bak [63, 88]. The mechanism through which
B a x( a n dB a k )f a v o r sE RC a 2+ release is currently debated.
Recent cell-free studies have shown that Bax forms small
pores, compatible with multi-ion passage, on membranes
[89], thus possibly directly allowing Ca2+ leakage. Other
studiesindicateanindirectrole,thatis,favoringIP3 channels
opening [90, 91]. Ca2+ release from ER in turn favors the
recruitment of more Bax molecules from the cytosol to
ER membranes [88], thus amplifying the Ca2+-dependent
apoptotic signal [71]. Thus, the pro-apoptotic functions of
Bax and Bak are not limited to mitochondria, but consist of a
dualconcertedroleplayedatanearlierpre-commitmentstep
at the level of ER membranes, promoting Ca2+ movements;
and at a later step in mitochondria to promote MOMP
and the release of the apoptotic factors. It remains to be
clariﬁed if the mechanism of Bax translocation to ER in pre-
apoptosis occurs with the same mechanism as mitochondrial
translocation, that is, if there is a role for t-Bid or other BH3-
only proteins of the Bcl-2 family; moreover, it is still unclearInternational Journal of Cell Biology 7
if Bax domains involved in promoting ER Ca2+ leakage
coincide with those required for releasing the apoptotic
factors from mitochondria.
3.5. Calpain and Apoptosis. A role for the cysteine proteases
calpains, which are activated by Ca2+ increase, was investi-
gated since the earlier studies of apoptotic signaling, consid-
ering that (a) cytosolic Ca2+ overload was then considered as
themainmediatorofapoptosis[92],and(b)apoptosismight
be conceivably executed by coordinate protein dismantling
(which was later demonstrated for caspases) [58, 93]. The
focuswasplacedontheknowncalpaintargetfodrin[94],the
protein bridging plasma membrane with the cortical actin
cytoskeleton; it was hypothesized that fodrin degradation
might destabilize the cytoskeleton-membrane asset and
promote plasma membrane blebbing [95], one of the earliest
apoptotic features described [96]; however, such evidences
have not been conﬁrmed; actually, calpain activation seems
rather inhibiting plasma membrane blebbing (De Nicola et.
al, in preparation).
Nowadays, many pieces of evidence show that calpains
are required for apoptosis in some systems [97–100], being
dispensable (or not involved) in others [101]; when calpains
are involved, they act at a very early step, upstream of
caspases [100, 102], thus participating to the commitment
phase of signaling rather than to the execution. The notion
that the form of calpain involved in apoptosis is m-calpain
[103], the one also involved in cell stress [20] and that
requires high (mM) Ca2+ levels (as opposed to μ-calpain,
involved in cell signaling, and requiring lower, μMd o s e s )
wasveryimportantbecauseitallowedlinkingenvironmental
alterations to apoptosis via Ca2+ overload. The molecular
role for calpain in promoting apoptosis is still under
investigation. Perhaps the most clear-cut hint is the calpain-
mediated proteolytic Bax activation [70, 104], one of the
few mechanisms so far proposed for direct Bax activation
by cell damage [104–106]. Two mitochondrial calpains co-
operate in the release of a truncated active form of AIF
(tAIF) thus promoting apoptosis: a matrix m-calpain cleaves
AIF [107]; and a transmembrane μ-calpain cleaves VDAC,
promoting the formation of Bax-VDAC pores on the outer
mitochondrial membrane and the release of tAIF [108].
A complex interplay between calpain and caspasesoccurs
in apoptosis. Calpain have been proposed to proteolytically
activate some caspases [100, 109–112]; paradoxically, cas-
pases may also be degraded by calpains [113], which in
such instances would act to prevent, rather than promote,
apoptosis; the factors inﬂuencing this discrepant behavior
have not been clariﬁed.
4.Ca2+ andthe Stress Response
4.1. Generalities. Stress consists of any physico-chemical
alteration of cell environment that interferes with cell
functioning,potentiallyoractuallyproducingdamage.Stress
elicits active cell responses that, according to cell type, and
to type and extent of damage, aim at cell survival (cell-
protective and/or cell-reparative stress response, such as the
heat shock response) or cell death (apoptosis).
Stress responses are speciﬁc for a given type of alter-
ation/damage:heat,oxidation,hypoxia,starvation,alltrigger
the synthesis or activation of molecular determinants ade-
quate to cope with the speciﬁc type of damage; for example,
heat shock will induce synthesis of molecular chaperones
to cope with exposure of hydrophobic residues of proteins
[114]; oxidative stress will induce the synthesis/activation
of anti-oxidant enzymes or molecules [115]; hypoxia pro-
motes anaerobic metabolism [116]; starvation promotes
the disassembly of whole cell areas that are digested by
autophagy [117], in order to recycle the building blocks for
housekeeping purposes. This speciﬁcity of response limits
the cross-resistance between diﬀerent stress, even though a
partial overlapping exist.
A brief/mild insult is often suﬃcient to trigger protective
responses but not to produce damage. This protects the cells
from a second, more severe insult of the same type, thus
producing transient tolerance to further stress, as occurring,
for example, during thermotolerance [118]. Treatments with
important clinical relevance, such as ischemia precondition-
ing,thatisashortanoxictreatmentthatisprotectivetowards
a more severeischemia, and whosemechanisms arestill to be
elucidated at the molecular level, seem to depend on Ca2+
signaling [119]. Ca2+ participates as second messenger to
such defensive, reparative, or survival pathways, propagating
the cell-protective signals.
High [Ca2+]c is involved in the stimulation of the
autophagic response through the activation of calcium/
calmodulin-dependent kinase-b that inhibits mTOR [120],
the main negative regulator of authophagic processes in
mammals,withthegoalofeliminatingcellularareasthatmay
be damaged by Ca2+ overload.
4.2. Ca2+ in Cell Survival. In addition to these speciﬁc stress
responses, cells are capable to build up survival pathways
that render them less prone to apoptosis, thus promoting cell
survival whatever the type of damage; this especially occurs
in cells that reside in highly stressing environments, such as
inﬂammatory or immune cells while exerting their functions
[121], or transformed cells undergoing tumor progression
[122], process in which cells carrying apoptosis-resistant
mutations are favored by natural selection.
Ca2+ is involved in pro-survival or anti-apoptotic path-
ways, such as the activation of protein kinase C, whose
many isoforms play pivot roles in coordinating survival cell
responses [123].
Capacitative Ca2+ entry (CCE) is Ca2+ inﬂux from
the extracellular environment through speciﬁc and tightly
controlled plasma membrane channels [4, 5]. CCE only
transiently crosses the cytosol, its aims being rather the
replenishment of ER, after it was partially emptied by
signaling events such as cyclic ADP-ribose- [4]o rI P 3-
mediatedopeningofERCa2+ channels[5].CCEpoorlyalters
cytosolic homeostasis, but prevents ER vesiculation due to
Ca2+ emptying, thus being a net cell-protective event.
Recently, another mechanism of Ca2+ inﬂux is being
considered, namely the noncapacitative Ca2+ inﬂux (NCCE)
[124], a non-store-operated mechanism that allows Ca2+
entry through plasma membrane channels that are diﬀerent8 International Journal of Cell Biology
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Figure 2: Capacitative and noncapacitative Ca2+ entry. Ligand (L) stimulation of G-protein (αβγ)-coupled receptor (R) activates
phospholipase C (PLC) to produce diacylglycerol (DAG) and inositol-3-phosphate (IP3). IP3 (right side) causes ER Ca2+ emptying, eliciting
a capacitative Ca2+ entry (CCE) through plasma membrane (PM), aimed at reﬁlling ER of Ca2+ restoring ER homeostasis. DAG (left side)
is processed to arachidonic acid (AA) by DAG lipase (DAGL), stimulating NOS to produce NO, which activates Ca2+ entry through PM
by a noncapacitative Ca2+ entry (NCCE), priming speciﬁc signaling including anti-apoptotic pathways. CCE and NCCE diﬀer in protein
composition [124]. Red dots symbolize Ca2+.
from those of CCE from the molecular and regulative
point of view. As depicted in Figure 2, NCCE, as CCE,
occurs as a response to receptor stimulation implying G-
protein and phospholipase C (PLC) but, unlike CCE, it
does not respond to IP3-induced ER emptying; instead,
it results from the processing of diacylglycerol (the other
product of inositol-bis-phosphate cleavage by PLC), which
promotes a signal transduction chain culminating with
NCCE assembly. Interestingly, NCCE occurs also in non-
excitable cells. Even though mechanisms and functions are
stillpoorlycharacterized,itisclearthatCa2+ entryviaNCCE
has a signaling function, possibly implying the control of
survival pathways. Interestingly, it requires production of
NO, a molecule that is involved in many survival pathways
[125], including a strict interrelationship with protein kinase
C[ 124]. Agents promoting cell survival such as magnetic
ﬁelds reduce stress-induced apoptosis by increasing Ca2+
inﬂux [126, 127], involving NCCE rather than CCE (Cerella
and Ghibelli, in preparation).
4.3. Stand-By Mechanisms. The decision between cell repair
or demise of damaged cells is a choice between the risk
of mal-repair, leading to stabilize mutations and poten-
tially preserve precancerous cells, versus loss of viable cells
performing useful functions, which must be expensively
replaced. Even though the former risk is deﬁnitely worse
than the latter, mechanisms aiming at avoiding unnecessary
loss of precious cells have evolved. To this purpose, it is
importantthatdamagedcellsdonotinitiateapoptosisbefore
attempting to repair the damage: this is actively achieved by
damaged cells via the set-up of reversible standby scenarios,
during which apoptotic signaling is transiently kept at bay.
One of such standby mechanisms implies that potentially
apoptogenic stress conditions such as H2O2 treatment
cause the transient inhibition of glycolysis mediated by the
reversible ADP-ribosylation of glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH) [128]; this inactivates ER Ca2+-
ATPases, which are fed by glycolytic ATP [129], thus
decreasing ER Ca2+ while increasing [Ca2+]c and impairing
Ca2+-mediated cell signaling. Many pieces of evidence from
the literature show that cells with partial Ca2+-depleted ER
cannot initiate apoptosis [130–132], and indeed, during the
standby period of glycolysis block, apoptosis cannot initiate
[128]. Starting at around 90 minutes after recovering from
H2O2 stress, glycolysisresumes [128],ER Ca2+ increases, and
[Ca2+]c is reduced [64]; only then H2O2-induced apoptosis
begins [128]; (Cerella et al., in preparation). Similar ﬁndings
were reported also for other, oxidation-unrelated apopto-
genic agents, strongly supporting the scenario according
to which (a) Ca2+ signaling is required for stress-induced
apoptosis [64], and (b) ER is the initiator of the apoptotic
signaling, since the standby phase seems to prevent ER from
amplifying apoptotic signal and mitochondrial recruitment.
A model representing the relationship between apoptogenic,
repair and standby signals in damaged cells is shown in
Figure 3.
5. Conclusions
The relationship between Ca2+ and cell death has a long
and complex story. It was a reasonably simple task when the
goal was describing how strongly deregulated intracellular
Ca2+ may cause the passive cell death by necrosis. The
scenario became very much complex when the increas-
ing information of the mechanisms of Ca2+-mediated cell
signaling in general, and apoptotic signaling in particular,
begun to merge. Figure 4 depicts the diﬀerent roles that
Ca2+ alterations, as an intrinsic stressor, play in the survival
or death of damaged cells, aiming at separating Ca2+
deregulation from pro-apoptotic Ca2+ signaling. PerhapsInternational Journal of Cell Biology 9
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Figure 3: Temporary ER Ca2+ anergy avoid loss of repairable cells.
Cell damage elicits repair and apoptosis as well as standby periods
(red arrows). ER Ca2+ anergy is temporarily achieved via ADP-
ribosylation of GAPDH, glycolysis block and starvation of Ca2+-
ATPases, and hampers apoptotic signal transduction at the ER
signaling stage. After resumption of glycolysis and ER Ca2+ activity,
the apoptotic signal is allowed to proceed, unless successful repair
has occurred in the meantime.
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Figure 4: Ca2+ signaling in survival and apoptosis versus deregula-
tion of Ca2+ homeostasis as necrogenic event.
the hottest topic to-date in this ﬁeld is the role that ER,
and the Ca2+ messages it exchanges with mitochondria,
plays in the ampliﬁcation of the apoptotic signal, ending
up with the promotion of MOMP and the trigger of the
commitment phase of the intrinsic apoptotic signaling. The
ampliﬁcation loops created by the concerted action of ER,
Bax, IP3 channels and cytochrome c with Ca2+ signals,
spanning ER and mitochondria via cytosol, as depicted in
Figure 1, are beginning to deﬁne a novel precommitment
phase of apoptosis. This is a very important issue because,
unlike the extrinsic apoptotic pathway, which has been very
well characterized at the molecular level since many years,
the molecular events of the intrinsic pathway upstream of
MOMP are poorly understood. From the functional point
of view, a precommitment phase might have the role of
selecting, among the pro-apoptotic signals deriving from cell
damage, the ones that have to be ﬁnalized in cell death,
thus avoiding unnecessary cell loss. Unlike receptor-induced
apoptosis, beforecommitmenttodamage-inducedapoptosis
cells must check the extent of the damage, and the possibility
to repair it, before engaging the apoptotic signaling and
commit suicide. To this purpose, diﬀerent signals reporting
the nature and the extent of the damage must merge into a
mainstreamsignalthatactuallyallowstheonsetofapoptosis,
which in molecular terms coincides with MOMP. Many
evidences allow proposing the fascinating scenario according
to which ER plays as a pivot that receives the damage signals
and select those that actually deserve ending up in apoptosis.
The acknowledgement of a Ca2+-dependent pre-com-
mitment apoptotic phase would place Ca2+-related events
among the earliest of apoptosis, which would make the
closing of a circle that begun almost 20 years ago, when Ca2+
as an intrinsic stressor was considered as “the” mediator of
apoptosis.
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